Evidence map›Paper›PMID 20589067›Full record

ArticleJournal of biomedicine & biotechnology2010

Maintenance or emergence of chronic phase secondary cytotoxic T lymphocyte responses after loss of acute phase immunodominant responses does not protect SIV-infected rhesus macaques from disease progression.

M Shannon Keckler, Vida L Hodara, Laura M Parodi, Luis D Giavedoni

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedicine & biotechnology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M Shannon KecklerUniversity of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.
Vida L Hodara
Laura M Parodi
Luis D Giavedoni
Texas Biomedical Research Institute · US

Funding

WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI GAUDUIN, MARIE-CLAIRE ELISABETH · 1999 to 2011
$79.1M
Immunogenicity of HSV Amplicons in Rhesus MacaquesR21AI055369 · NIAID · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI GIAVEDONI, LUIS DAVID · 2003 to 2004
$503k
Multiplex MHC Typing of Rhesus MacaquesR03AI055443 · NIAID · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI GIAVEDONI, LUIS DAVID · 2003 to 2004
$169k
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR012087 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI VANDEBERG, JOHN L · 1996 to 1996
–
NCRR NIH HHS C06 RR012087NCRR NIH HHS C06 RR12087NCRR NIH HHS P51 RR013986NIAID NIH HHS R03 AI055443NIAID NIH HHS R03 AI55443NIAID NIH HHS R21 AI055369NIAID NIH HHS R21 AI55369
6 · The paper itself

Abstract

The simian immunodeficiency virus- (SIV-) infected rhesus macaque is the preferred animal model for vaccine development, but the correlates of protection in this model are not completely understood. In this paper, we document the cytotoxic T lymphocyte (CTL) response to SIV and its effects on viral evolution in an effort to identify events associated with disease progression regardless of MHC allele expression. We observed the evolution of epitopes targeted by CTLs in a group of macaques that included long-term nonprogressing (LTNP), slowly progressing (SP), normally progressing (NP), and rapidly progressing (RP) animals. Collectively, our data (1) identify novel CTL epitopes from an SP animal that are not restricted by known protective alleles, (2) illustrate that, in this small study, RP and NP animals accrue more mutations in CTL epitopes than in SP or LTNP macaques, and (3) demonstrate that the loss of CTL responses to immunodominant epitopes is associated with viral replication increases, which are not controlled by secondary CTL responses. These findings provide further evidence for the critical role of the primary cell-mediated immune responses in the control of retroviral infections.

Indexed as

Disease ProgressionHost-Pathogen InteractionsAcute DiseaseAnimalsEpitopes, T-LymphocyteEvolution, MolecularImmunoassayMacaca mulattaMutationSAIDS VaccinesSimian Immunodeficiency VirusStatistics, NonparametricT-Lymphocytes, CytotoxicEpitopes, T-LymphocyteSAIDS Vaccines

Identifiers

PMID20589067
PMCPMC2877203
OpenAlexW2031517069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.